Goldman Sachs Starts Revance Therapeutic (RVNC) at Buy

December 2, 2019 4:30 AM

Goldman Sachs analyst Terence Flynn initiates coverage on Revance Therapeutic (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found